The Food and Drug Administration is expected to authorize Pfizer-BioNTech’s Covid-19 booster shot for all adults within days, according to a person familiar with the plans.
The FDA’s action could come as early as Thursday. The news was first reported by The New York Times.
The Centers for Disease Control and Preventon’s vaccine advisory committee is scheduled to meet Friday to discuss boosters.
